Applications of ESI-MS in drug discovery: Interrogation of noncovalent complexes

Nature Reviews Drug Discovery

Volumn 5, Issue 7, 2006, Pages 585-595

  Hofstadler, Steven A ^a   Sannes Lowery, Kristin A ^a  

^a ISIS PHARMACEUTICALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG;

CHEMICAL INTERACTION; COLLISIONALLY ACTIVATED DISSOCIATION; DISSOCIATION CONSTANT; DRUG ABSORPTION; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG IDENTIFICATION; DRUG METABOLISM; DRUG PURITY; DRUG RESEARCH; DRUG SCREENING; DRUG TARGETING; ELECTROSPRAY MASS SPECTROMETRY; FOURIER TRANSFORM MASS SPECTROMETRY; INFRARED SPECTROMETRY; ION MOBILITY SPECTROMETRY; MACROMOLECULE; MASS SPECTROMETRY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVIEW; STRUCTURE ACTIVITY RELATION;

ANIMALS; DNA; DRUG DESIGN; DRUG EVALUATION, PRECLINICAL; HUMANS; LIGANDS; NANOTECHNOLOGY; PROTEIN BINDING; PROTEINS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

EID: 33745652264     PISSN: 14741776     EISSN: 14741784     Source Type: Journal    
DOI: 10.1038/nrd2083     Document Type: Review

References (91)

1. Lee, M. S. Integrated Strategies for Drug Discovery Using Mass Spectrometry (John Wiley & Sons, Hoboken New Jersey, 2005).
2. Zhang, J., McCombie, G., Guenat, C. & Knochenmuss, R. FT-ICR mass spectrometry in the drug discovery process. Drug Discov. Today 10, 635-642 (2005).
3. Siegel, M. M. Early discovery drug screening using mass spectrometry. Curr. Topics Med. Chem. 2, 13-33 (2002).
4. Hofstadler, S. A. & Griffey, R. H. Analysis of noncovalent complexes of DNA and RNA by mass spectrometry. Chem. Rev. 101, 377-390 (2001).
5. Hofstadler, S. A. & Griffey, R. H. Mass spectrometry as a drug discovery platform against RNA targets. Curr. Opin. Drug Discov. Dev. 3, 423-431 (2000).
6. De Stasio, E. A., Moazed, D., Noller, H. F. & Dahlberg, A. E. Mutations in 16S ribosomal RNA disrupt antibiotic - RNA interactions. EMBO J. 8, 1213-1216 (1989).
7. Bryan, L. E. in New dimensions in Antimicrobial Therapy (eds Root, R. K. & Sande, M. A.) 17-35 (Churchill Livingstone, New York, 1984).
8. Wong, C.-H., Hendrix, M., Priestley, E. S. & Greenberg, W. A. Specificity of aminoglycoside antibiotics for the A-site of the decoding region of ribosomal RNA. Chem. Biol. 5, 397-406 (1998).
9. Ganem, B., Li, Y.-T. & Henion, J. D. Detection of Noncovalent Receptor-Ligand Complexes by Mass Spectrometry. J. Am. Chem. Soc. 113, 6294-6296 (1991).
10. Smith, R. D., Light-Wahl, K. J., Winger, B. E. & Loo, J. A. Preservation of noncovalent associations in electrospray ionization mass-spectrometry - multiply charged polypeptide and protein dimers. Organic Mass Spectrometry 27, 811-821 (1992).
11. Loo, J. A. Bioanalytical mass spectrometry: Many flavors to choose. Bioconjug. Chem. 6, 644-665 (1995).
12. Loo, J. A. Studying noncovalent protein complexes by electrospray ionization mass spectrometry. Mass Spectrom. Rev. 16, 1-23 (1997).
13. Bruce, J. E. et al. Bio-affinity characterization mass spectrometry. Rapid Commun. Mass Spectrom. 9, 644-650 (1995).
14. van den Heuvel, R. H. & Heck, A. J. Native protein mass spectrometry: from intact oligomers to functional machineries. Curr. Opin. Chem. Biol. 8, 519-526 (2004).
15. Breuker, K. The study of protein-ligand interactions by mass spectrometry - a personal view. Int. J. Mass Spectrom. 239, 33-41 (2004).
16. Beck, J. L., Colgrave, M. L., Ralph, S. F. & Sheil, M. M. Electrospray ionization mass spectrometry of oligonucleotide complexes with drugs, metals, and proteins. Mass Spectrom. Rev. 20, 61-87 (2001).
17. Kempen, E. C. & Brodbelt, J. S. A method for the determination of binding constants by electrospray ionization mass spectrometry. Anal. Chem. 72, 5411-5416 (2000).
18. Griffey, R. H. et al. Characterization of low-affinity complexes between rna and small molecules using electrospray ionization mass spectrometry. J. Am. Chem. Soc. 122, 9933-9938 (2000).
19. Griffey, R. H., Hofstadler, S. A., Sannes-Lowery, K. A., Ecker, D. J. & Crooke, S. T. Determinants of aminoglycoside-binding specificity for rRNA by using mass spectrometry. Proc. Natl Acad. Sci. USA 96, 10129-10133 (1999).
20. Sannes-Lowery, K. A., Griffey, R. H. & Hofstadler, S. A. Measuring dissociation constants of RNA and aminoglycoside antibiotics by electrospray ionization mass spectrometry. Anal. Biochem. 280, 264-271 (2000).
21. Hensley, P. Defining the structure and stability of macromolecular assemblies in solution: The re-emergence of analytical ultracentrifugation as a practical tool. Structure 4, 367-373 (1996).
22. Smith, D. L. & Zhang, Z. Q. Probing noncovalent structural features of proteins by mass spectrometry. Mass Spectrom. Rev. 13, 411-429 (1994).
23. Lakey, J. H. & Raggett, E. M. Measuring protein-protein interactions. Curr. Opin. Struct. Biol. 8, 119 (1998).
24. Lim, H. K., Hsieh, Y. L., Ganem, B. & Henion, J. Recognition of cell-wall peptide ligands by vancomycin group antibiotics: Studies using ion spray mass spectrometry. J. Mass Spectrom. 30, 708-714 (1995).
25. Jorgensen, T. J. D. & Roepstorff, P. Direct determination of solution binding constants for noncovalent complexes between bacterial cell wall peptide analogues and vancomycin group antibiotics by electrospray ionization mass spectrometry. Anal. Chem 70, 4427-4432 (1998).
26. Jorgensen, T. J. D., Delforge, D., Remacle, J., Bojesen, G. & Roepstorff, P. Collision-induced dissociation of noncovalent complexes between vancomycin antibiotics and peptide ligand stereoisomers: evidence for molecular recognition in the gas phase. Int. J. Mass Spectrom. 188, 63-85 (1999).
27. Jorgensen, T. J. D., Hvelplund, P., Andersen, J. U. & Roepstorff, P. Tandem mass spectrometry of specific vs. nonspecific noncovalent complexes of vancomycin antibiotics and peptide ligands. Int. J. Mass Spectrom. 219, 659-670 (2002).
28. Jorgensen, T. J. D., Staroske, T., Roepstorff, P., Williams, D. H. & Heck, A. J. R. Subtle differences in molecular recognition between modified gylcopeptide antibiotics and bacterial receptor peptides identified by electrospray ionization mass spectrometry. J. Chem. Soc., Perkin Trans. 2, 1859-1863 (1999).
29. van de Kerk-van Hoof, A. & Heck, A. J. Interactions of α- and β-avoparcin with bacterial cell-wall receptor-mimicking peptides studied by electrospray ionization mass spectrometry. J. Antimicrob. Chemother. 44, 593-599 (1999).
30. van de Kerk-van Hoof, A. & Heck, A. J. R. Covalent and non-covalent dissociations of gas-phase complexes of avoparcin and bacterial receptor mimicking precursor peptides studied by collisionally activated decomposition mass spectrometry. J. Mass Spectrom. 34, 813-819 (1999).
31. Coulson, C. J. Molecular Mechanisms fo Drug Action (Taylor & Francis, London, 1994).
32. Robinson, C. V. et al. Probing the nature of noncovalent interactions by mass spectrometry. A study of protein-CoA ligand binding and assembly. J. Am. Chem. Soc. 118, 8646-8653 (1996).
33. Wu, Q. Y. et al. Carbonic anhydrase-inhibitor binding: From solution to the gas phase. J. Am. Chem. Soc. 119, 1157-1158 (1997).
34. Rogniaux, H. et al. Binding of aldose reductase inhibitors: Correlation of crystallographic and mass spectrometric studies. J. Am. Soc. Mass Spectrom. 10, 635-647 (1999).
35. Nesatyy, V. J. Gas-phase binding of non-covalent protein complexes between bovine pancreatic trypsin inhibitor and its target enzymes studied by electrospray ionization tandem mass spectrometry. J. Mass Spectrom. 36, 950-959 (2001).
36. Daniel, J. M., Friess, S. D., Rajagopalan, S., Wendt, S. & Zenobi, R. Quantitative determination of noncovalent binding interactions using soft ionization mass spectrometry. Int. J. Mass Spectrom. 216, 1-27 (2002).
37. Cheng, X. et al. Using electrospray ionization FTICR mass spectrometry to study competitive binding of inhibitors to carbonic anhydrase. J. Am. Chem. Soc. 117, 8859-8860 (1995).
38. Gao, J. et al. Screening derivatized peptide libraries for tight binding inhibitors to carbonic anhydrase II by electrospray ionization-mass spectrometry. J. Med. Chem. 39, 1949-1955 (1996).
39. Gao, J. et al. Probing the energetics of dissociation of carbonic anhydrase-ligand complexes in the gas phase. Biophys. J. 76, 3253-3260 (1999).
40. Wigger, M., Eyler, J. R., Benner, S. A., Li, W. & Marshall, A. G. Fourier transform-ion cyclotron resonance mass spectrometric resolution, identification, and screening of non-covalent complexes of Hck Src homology 2 domain receptor and ligands from a 324-member peptide combinatorial library. J. Am. Soc. Mass Spectrom. 13, 1162-1169 (2002).
41. Grucza, R. A., Bradshaw, J. M., Futterer, K. & Waksman, G. SH2 domains: from structure to energetics, a dual approach to the study of structure-function relationships. Med. Res. Rev. 19, 273-293 (1999).
42. Koch, C. A., Anderson, D., Moran, M. F., Ellis, C. & Pawson, T. SH2 and SH3 domains: Elements that control interactions of cytoplasmic signaling proteins. Science 252, 668-674 (1991).
43. Courtneidge, S. A. Protein tyrosine kinases, with emphasis on the Src family. Semin. Cancer Biol. 5, 239-246 (1994).
44. Courtneidge, S. A. Role of Src in signal transduction pathways. The Jubilee Lecture. Biochem. Soc. Trans. 30, 11-17 (2002).
45. Guan, S. H. & Marshall, A. G. Stored waveform inverse Fourier transform (SWIFT) ion excitation in trappedion mass spectometry: Theory and applications. Int. J. Mass Spectrom. Ion Process. 158, 5-37 (1996).
46. Little, D. P., Speir, J. P., Senko, M. W., O'Connor, P. B. & McLafferty, F. W. Infrared multiphoton dissociation of large multiply charged ions for biomolecule sequencing. Anal. Chem. 66, 2809-2815 (1994).
47. Dufresne, C. P., Wood, T. D. & Hendrickson, C. L. High- resolution electrospray ionization Fourier transform mass spectrometry with infrared multiphoton dissociation of glucokinase from Bacillus stearothermophilus. J. Am. Soc. Mass Spectrom. 9, 1222-1225 (1998).
48. Loo, J. A., Hu, P., McConnell, P. & Mueller, W. T. A study of Src SH2 domain protein-phosphopeptide binding interactions by electrospray ionization mass spectrometry. J. Am. Soc. Mass Spectrom. 8, 234-243 (1997).
49. Chung, E. et al. Mass spectrometric and thermodynamic studies reveal the role of water molecules in complexes formed between SH2 domains and tyrosyl phosphopeptides. Structure 6, 1141-1151 (1998).
50. Chung, E. W. et al. Probing the nature of interactions in SH2 binding interfaces - evidence from electrospray ionization mass spectrometry. Protein Sci. 8, 1962-1970 (1999).
51. Bligh, S. W., Haley, T. & Lowe, P. N. Measurement of dissociation constants of inhibitors binding to Src SH2 domain protein by non-covalent electrospray ionization mass spectrometry. J. Mol. Recognit. 16, 139-148 (2003).
52. Larson, E. R., Lipinski, C. A. & Sarges, R. Medicinal chemistry of aldose reductase inhibitors. Med. Res. Rev. 8, 159-186 (1988).
53. Nesatyy, V. J. Mass spectrometry evaluation of the solution and gas-phase binding properties of noncovalent protein complexes. Int. J. Mass Spectrom. 221, 147-161 (2002).
54. McCammon, M. G. et al. Screening transthyretin amyloid fibril inhibitors: Characterization of novel multiprotein, multiligand complexes by mass spectrometry. Structure 10, 851-863 (2002).
55. McCammon, M. G., Hernandez, H., Sobott, F. & Robinson, C. V. Tandem mass spectrometry defines the stoichiometry and quaternary structural arrangement of tryptophan molecules in the multiprotein complex TRAP. J. Am. Chem. Soc. 126, 5950-5951 (2004).
56. Pepys, M. B. et al. Targeting C-reactive protein for the treatment of cardiovascular disease. Nature 440, 1217-1221 (2006).
57. Kelly, J. W. Amyloid fibril formation and protein misassembly: A structural quest for insights into amyloid and prion diseases. Structure 5, 595-600 (1997).
58. Koo, E. H., Lansbury, P. T., Jr. & Kelly, J. W. Amyloid diseases: abnormal protein aggregation in neurodegeneration. Proc. Natl Acad. Sci. USA 96, 9989-9990 (1999).
59. Petrassi, H. M., Klabunde, T., Sacchettini, J. & Kelly, J. W. Structure-based design of N-phenyl phenoxazine transthyretin amyloid fibril inhibitors. J. Am. Chem. Soc. 122, 2178-2192 (2000).
60. Benkestock, K., Edlund, P. O. & Roeraade, J. Electrospray ionization mass spectrometry as a tool for determination of drug binding sites to human serum albumin by noncovalent interaction. Rapid Commun. Mass Spectrom. 19, 1637-1643 (2005).
61. Gabelica, V., De Pauw, E. & Rosu, F. Interaction between antitumor drugs and a double-stranded oligonucleotide studied by electrospray ionization mass spectrometry. J. Mass Spectrom. 34, 1328-1337 (1999).
62. Rosu, F., Gabelica, V., Houssier, C. & De Pauw, E. Determination of affinity, stoichiometry and sequence selectivity of minor groove binder complexes with double-stranded oligodeoxynucleotides by electrospray ionization mass spectrometry. Nucleic Acids Res. 30, e82 (2002).
63. Kapur, A., Beck, J. L. & Sheil, M. M. Observation of daunomycin and nogalamycin complexes with duplex DNA using electrospray ionization mass spectrometry. Rapid Commun. Mass Spectrom. 13, 2489-2497 (1999).
64. Gupta, R., Kapur, A., Beck, J. L. & Sheil, M. M. Positive ion electrospray ionization mass spectrometry of double-stranded DNA/drug complexes. Rapid Communications in Mass Spectrometry 15, 2472-2480 (2001).
65. Gupta, R., Beck, J. L., Ralph, S. F., Sheil, M. M. & Aldrich-Wright, J. R. Comparison of the binding stoichiometries of positively charged DNA-binding drugs using positive and negative ion electrospray ionization mass spectrometry. J. Am. Soc. Mass Spectrom. 15, 1382-1391 (2004).
66. Wan, K. X., Gross, M. L. & Shibue, T. Gas-phase stability of double-stranded oligodeoxynucleotides and their noncovalent complexes with DNA-binding drugs as revealed by collisional activation in an ion trap. J. Am. Soc. Mass Spectrom. 11, 450-457 (2000).
67. Wan, K. X., Shibue, T. & Gross, M. L. Non-covalent complexes between DNA-binding drugs and double-stranded oligodeoxynucleotides: A study by ESI ion-trap mass spectrometry. J. Am. Chem. Soc. 122, 300-307 (2000).
68. Oehlers, L., Mazzitelli, C. L., Brodbelt, J. S., Rodriguez, M. & Kerwin, S. Evaluation of complexes of DNA duplexes and novel benzoxazoles or benzimidazoles by electrospray ionization mass spectrometry. J. Am. Soc. Mass Spectrom. 15, 1593-1603 (2004).
69. Triolo, A., Arcamone, F. M., Raffaelli, A. & Salvadori, P. Non-covalent complexes between DNA-binding drugs and double-stranded deoxyoligonucleotides: A study by ionspray mass spectrometry. J. Mass Spectrom. 32, 1186-1194 (1997).
70. Greig, M. J. & Robinson, J. M. Detection of oligonucleotide-ligand complexes by ESI-MS (DOLCE-MS) as a component of high throughput screening. J. Biomol. Screening 5, 441-454 (2000).
71. Hermann, T. & Patel, D. J. Adaptive recognition by nucleic acid aptamers. Science 287, 820-825 (2000).
72. Ramos, A., Gubser, C. C. & Varani, G. Recent solution structures of RNA and its complexes with drugs, peptides and proteins. Curr. Opin. Struct. Biol. 7, 317-323 (1997).
73. Conn, G. L. & Draper, D. E. RNA structure. Curr. Opin. Struct. Biol. 8, 278-285 (1998).
74. Hofstadler, S. A. et al. Multiplexed screening of neutral mass-tagged rna targets against ligand libraries with electrospray ionization FTICR MS: A paradigm for high-throughput affinity screening. Anal. Chem. 71, 3436-3440 (1999).
75. Sannes-Lowery, K. A., Drader, J. J., Griffey, R. H. & Hofstadler, S. A. Fourier transform ion cyclotron resonance mass spectrometry as a high throughput affinity screen to identify RNA-binding ligands. Trends Anal. Chem. 19, 481-491 (2000).
76. Wang, X., Migawa, M. T., Sannes-Lowery, K. A. & Swayze, E. E. The synthesis and 16S A-site rRNA recognition of carbohydrate-free aminoglycosides. Bioorg. Med. Chem. Lett. 15, 4919-4922 (2005).
77. He, Y. et al. Synthesis and evaluation of novel bacterial rRNA-binding benzimidazoles by mass spectrometry. Bioorg. Med. Chem. Lett. 14, 695-699 (2004).
78. Seth, P. P. et al. SAR by MS: Discovery of a new class of RNA-binding small molecules for the hepatitis C virus: Internal ribosome entry site IIA subdomain. J. Med. Chem. 48, 7099-7102 (2005).
79. Swayze, E. E. et al. SAR by MS: A ligand based technique for drug lead discovery against structured RNA targets. J. Med. Chem. 45, 3816-3819 (2002).
80. Recht, M. I., Fourmy, D., Blanchard, S. C., Dahlquist, K. D. & Puglisis, J. D. RNA sequence determinants for aminoglycoside binding to an A-site rRNA model oligonucleotide. J. Mol. Biol. 262, 421-436 (1996).
81. Cummins, L. L. et al. Multitarget affinity/specificity screening of natural products: Finding and characterizing high affinity ligands from complex mixtures by using high performance mass spectrometry. J. Nat. Prod. 66, 1186-1190 (2003).
82. Ockey, D. A. et al. Structure-activity relationships by mass spectrometry: Identification of novel MMP-3 inhibitors. Bioorg. Med. Chem. 12, 37-44 (2004).
83. Gabelica, V. et al. Advantages and drawbacks of nanospray for studying noncovalent protein-DNA complexes by mass spectrometry. Rapid Commun. Mass Spectrom. 16, 1723-1728 (2002).
84. Rostom, A. A. & Robinson, C. V. Disassembly of intact multiprotein complexes in the gas phase. Curr. Opin. Struct. Biol. 9, 135-141 (1999).
85. Benkestock, K., Sundqvist, G., Edlund, P. O. & Roeraade, J. Influence of droplet size, capillary-cone distance and selected instrumental parameters for the analysis of noncovalent protein-ligand complexes by nano-electrospray ionization mass spectrometry. J. Mass Spectrom. 39, 1059-1067 (2004).
86. Keetch, C. A. et al. Use of a microchip device coupled with mass spectrometry for ligand screening of a multi-protein target. Anal. Chem. 75, 4937-4941 (2003).
87. Zhang, S., Van Pelt, C. K. & Wilson, W. D. Quantitative determination of noncovalent binding interactions using automated nanoelectrospray mass spectrometry. Anal. Chem. 75, 3010-3018 (2003).
88. Benkestock, K. et al. Automated nano-electrospray mass spectrometry for protein-ligand screening by noncovalent interaction applied to human H-FABP and A-FABP. J. Biomol. Screen. 8, 247-256 (2003).
89. Sun, Y. & Cheng, J. Hydrolysis of lignocllulosic materials for ethanol production: Review. Bioresour. Technol. 83, 1-11 (2002).
90. Gidden, J. et al. Application of ion mobility to the gas-phase conformational analysis of polyhedral oligomeric silsesquioxanes (POSS). Int. J. Mass Spectrom. 222, 63-73 (2003).
91. Koeniger, S. L., Merenbloom, S. I. & Clemmer, D. E. Evidence for many resolvable structures within conformation types of electrosprayed ubiquitin ions. J. Phys. Chem. B 110, 7017-7021 (2006).